GlaxoSmithKline and Reliant Pharmaceuticals Inc. announced that
they had reached an agreement under which Reliant will be acquired
by GSK for $1.65 billion (?800 million) in cash. Reliant, a
privately held specialty pharmaceutical company focused on
cardiovascular therapies, recorded net sales of $341 million in the
nine months ending 30 September
1El Raton
GlaxoSmithKline and Reliant Pharmaceuticals Inc. announced that they had reached an agreement under which Reliant will be acquired by GSK for $1.65 billion (?800 million) in cash. Reliant, a privately held specialty pharmaceutical company focused on cardiovascular therapies, recorded net sales of $341 million in the nine months ending 30 September